Physician profile
John C Hodges
NPI 1619937273
$2,152.26
in general payments reported to CMS, 2019-2025
18 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $90.89 · 2021: $372 · 2022: $223 · 2023: $430 · 2024: $514 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.84 | 2023-2024 | Jardiance |
| Abbvie INC. | $360.93 | 2021-2025 | |
| Allergan, INC. | $299.98 | 2019-2021 | |
| Amgen INC. | $243.89 | 2021-2024 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $161.65 | 2023-2025 | Farxiga, Airsupra |
| Pacira Pharmaceuticals Incorporated | $123.08 | 2024 | Iovera |
| Janssen Pharmaceuticals, INC | $122.98 | 2019 | |
| Esperion Therapeutics, INC. | $119.93 | 2021 | |
| Horizon Therapeutics Plc | $97.60 | 2019-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $87.69 | 2019-2022 | |
| Pfizer INC. | $35.90 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $23.39 | 2022 | |
| Exact Sciences Corporation | $20.96 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $18.59 | 2019 | |
| Ironshore Pharmaceuticals INC. | $17.95 | 2023 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.32 | 2023 | Xifaxan |
| Lilly USA, LLC | $15.67 | 2023 | Trulicity, Mounjaro |
| Genentech USA, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.